Showing results (61-70 of 101) with videos related to
Sort By:
Pageof 11
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 30, 2022
Evaluation of an association between RANKL and OPG with bone disease in people with cystic fibrosisShadaan Abid, MinJae Lee, Bailey Rodich, et al.Obstetrics and Gynecology|October 2, 2025
Pregnancy in Patients With Cystic FibrosisBeth L Pineles, Raksha Jain, Traci M Kazmerski, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 12, 2023
A provider survey assessing fetal impact of CFTR modulator use in males with CF during assisted and unassisted reproduction and partner pregnancyJennifer L Taylor-Cousar, Rachel Janney, Peter G Middleton, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 18, 2020
Concerns regarding the safety of azithromycin in pregnancy - relevance for women with cystic fibrosisJennifer L Taylor-Cousar, Raksha Jain, Tracy M Kazmerski, et al.Contraception|February 29, 2020
Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient RegistryEmily M Godfrey, Sheila Mody, Malaika R Schwartz, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 3, 2018
KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosaRaksha Jain, V V Beckett, M W Konstan, et al.Infection and Drug Resistance|October 2, 2018
Multidrug-resistant <i>Pseudomonas aeruginosa</i> from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactamStan D Atkin, Shadaan Abid, Michael Foster, et al.BMJ Open Respiratory Research|June 16, 2022
Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study designRaksha Jain, Amalia Magaret, Phuong T Vu, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 6, 2010
Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndromeRaksha Jain, Ramsey R Hachem, Matthew R Morrell, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 29, 2024
Factors associated with prescription of elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis aged 12 years or older with at least one F508del alleleGeorgene E Hergenroeder, Jonathan V Todd, Josh S Ostrenga, et al.Pageof 11